-
Manufacturing
API & Intermediates Manufacturing
Commercial Plants
Anhui Ma’anshan c-GMP Manufacturing Site
-
Total Area：~945,000 ft2 -
1 GMP production line, scale up to hundreds of kgs per batch, 4 lines in plan
-
Reactors：~120, range from 500L- 5000L
-
Total volume: ~320,000L
ADC & HPAPI GMP Plants
Ma’anshan, Anhui Province — ADC & HPAPI Manufacturing
-
Total area : ~80,000 ft2
-
4 GMP HPAPI production lines, scale up to kgs
-
Total volume : 4,000L
-
Tofflon separator (OEL <1μg/m3 ) covering in the full spectrum of HPAPI of pharma
-
SOP controlled exposure: Maximum HPAPI safety is achieved by negative pressure separators for weighing, process development, pre-lyophilization handling. End-to-end production management in controlled working area
-
Scheduled monitoring: Air dust detection and alarm system, continuous staff training (SOP for PPE, emergency response, etc)
Shandong Heze Manufacturing Site
-
Total area: ~17,114 ft2
-
Reactors: 45, range from 500L - 5,000L, Scale up to hundreds of kgs per batch
-
Total volume: ~115,500L
Drug Product
Jiangsu GMP Manufacturing
-
Total area：~139,930 ft2
-
Oral solid dosages: 4 workshops; annual manufacturing capacity: ~1 billion units
-
Semi solid topical dosages: 2 workshop; annual manufacturing capacity: ~ 40 million tubes
-
GMP warehouses of various storage conditions including cold storage
-
Formulation development and manufacturing capabilities include tablets, hard capsules, granules, powders, creams, ointment and gels, including anti-tumor drugs
Learn About Our Products
